Breaking

RUTwo East Midlands Railway Trains Crash Near Bedford, Killing One and Injuring Dozens AUMan Dies in Fuel Tanker Rollover on Princes Freeway INTLH5N1 Bird Flu Strain Confirmed on Australian Mainland AUSenior doctors warn against unapproved weight loss drug retatrutide after liver damage cases USVLC Developer's Kyber Raises $5M for Real-Time Remote Device Control AUJosh Warneke's death: Coroner finds unlawful homicide, but killer remains unknown RUMorocco Defeats Scotland 1-0 in FIFA World Cup 2026 Group Stage INMeloni Fuming After Trump Claims She Begged for Selfie INTLTrump Administration Reportedly Aims to Denaturalize Hundreds of US Citizens AUBrazil vs Haiti: Match Preview and Team News RUTwo East Midlands Railway Trains Crash Near Bedford, Killing One and Injuring Dozens AUMan Dies in Fuel Tanker Rollover on Princes Freeway INTLH5N1 Bird Flu Strain Confirmed on Australian Mainland AUSenior doctors warn against unapproved weight loss drug retatrutide after liver damage cases USVLC Developer's Kyber Raises $5M for Real-Time Remote Device Control AUJosh Warneke's death: Coroner finds unlawful homicide, but killer remains unknown RUMorocco Defeats Scotland 1-0 in FIFA World Cup 2026 Group Stage INMeloni Fuming After Trump Claims She Begged for Selfie INTLTrump Administration Reportedly Aims to Denaturalize Hundreds of US Citizens AUBrazil vs Haiti: Match Preview and Team News

AI-driven drug design

Steady2 stories1 sourcesLast updated: 5/13/2026

Related TopicsMETiS TechBio Hong Kong stock market SpaceX pharmaceutical industry Hong Kong IPO AI in Pharma Drug Design SpaceX Comparison

Latest Stories

METiS TechBio debuts on Hong Kong stock market with 173% surge

5/13/2026AI summary

METiS TechBio debuts on Hong Kong stock market with 173% surge

METiS TechBio's shares surged 173% on their Hong Kong debut, with the AI-driven drug design start-up raising HK$2.11 billion from its initial public offering

METiS TechBio Debuts Strongly on Hong Kong Stock Market, Drawing SpaceX Comparison

5/13/2026AI summary

METiS TechBio Debuts Strongly on Hong Kong Stock Market, Drawing SpaceX Comparison

METiS TechBio, an AI-driven drug design start-up, made a strong debut on the Hong Kong stock market, raising HK$2.11 billion. CEO Lai Tsai-Ta compared the company to SpaceX, highlighting its use of AI algorithms for rapid drug development through nano-delivery platforms.